Rationale Chronic obstructive pulmonary disease (COPD) is associated with systemic inflammation and cardiovascular disease. Interaction between inflammatory cells and activated platelets is important ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

Background: A study was undertaken to evaluate exacerbations and their impact on the health related quality of life (HRQL) of patients with chronic obstructive pulmonary disease (COPD). Methods: A 2 ...

The American Lung Association’s virtual home assessment framework is based off of the Environmental Improvements for COPD and Asthma program to support individuals with improving disease management.

VIEW THE AGENDA Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading ...

EP: 7. Sotatercept for Patients with Pulmonary Arterial Hypertension EP: 8. The Role of the Prostacyclin Pathway EP: 9. Important Clinical Considerations for Pulmonary Arterial Hypertension EP: 10.

Abstract and Introduction Abstract Background: The clinical trial safety database for tiotropium has been augmented with a 4-year trial in patients with COPD, which provides an opportunity to ...

TNN Updated On Jun 16, 2025 at 02:56 PM IST ...

Nation’s first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programs LOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE ...

Pirfenidone has been shown to slow disease progression in patients with idiopathic pulmonary fibrosis (IPF). However, there are few treatment options for progressive fibrotic interstitial lung ...